glp-1 drugs for type 1 diabetes Medications Scripts for GLP-1, SGLT2 Drugs
Description
So the argument to be made is using the lowest GLP-1 dose possible to elicit gradual weight loss over time while optimizing diet, resistance exercise, etc
10.1172/JCI25483 50 HarderH.NielsenL.TuD
GLP-1 and amylin in the treatment of obesity
There is emerging evidence for GLP-1 receptor agonists as renoprotective agents, but their role in slowing progression to end-stage kidney disease is yet to be established
No statistically significant differences were observed for other neurodegenerative outcomes, including vascular dementia or Parkinsons disease
JCI Insight 6 (23), e93382
